Bharati R Dhruva
Examiner (ID: 3913)
Most Active Art Unit | 1632 |
Art Unit(s) | 1632 |
Total Applications | 2 |
Issued Applications | 1 |
Pending Applications | 1 |
Abandoned Applications | 0 |
Applications
Application number | Title of the application | Filing Date | Status |
---|---|---|---|
Array
(
[id] => 7503601
[patent_doc_number] => 08034791
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2011-10-11
[patent_title] => 'Activation of Egr-1 promoter by DNA damaging chemotherapeutics'
[patent_app_type] => utility
[patent_app_number] => 11/467799
[patent_app_country] => US
[patent_app_date] => 2006-08-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 18
[patent_figures_cnt] => 26
[patent_no_of_words] => 11703
[patent_no_of_claims] => 33
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 68
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/08/034/08034791.pdf
[firstpage_image] =>[orig_patent_app_number] => 11467799
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/467799 | Activation of Egr-1 promoter by DNA damaging chemotherapeutics | Aug 27, 2006 | Issued |
Array
(
[id] => 9085864
[patent_doc_number] => 08557289
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2013-10-15
[patent_title] => 'Nanoparticle suitable for delivery of a biomolecule into or out of a membrane enclosed cell or cell organelle'
[patent_app_type] => utility
[patent_app_number] => 11/990522
[patent_app_country] => US
[patent_app_date] => 2006-08-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 7
[patent_figures_cnt] => 7
[patent_no_of_words] => 5575
[patent_no_of_claims] => 8
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 285
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 11990522
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/990522 | Nanoparticle suitable for delivery of a biomolecule into or out of a membrane enclosed cell or cell organelle | Aug 20, 2006 | Issued |
Array
(
[id] => 5889903
[patent_doc_number] => 20060276427
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-12-07
[patent_title] => 'Regulation of endogenous gene expression in cells using zinc finger proteins'
[patent_app_type] => utility
[patent_app_number] => 11/505044
[patent_app_country] => US
[patent_app_date] => 2006-08-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 8
[patent_figures_cnt] => 8
[patent_no_of_words] => 29868
[patent_no_of_claims] => 3
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0276/20060276427.pdf
[firstpage_image] =>[orig_patent_app_number] => 11505044
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/505044 | Repressing endogenous CCR5 gene expression in cells using engineered zinc finger proteins | Aug 15, 2006 | Issued |
Array
(
[id] => 5153891
[patent_doc_number] => 20070036774
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2007-02-15
[patent_title] => 'Liver engrafting cells, assays, and uses thereof'
[patent_app_type] => utility
[patent_app_number] => 11/502210
[patent_app_country] => US
[patent_app_date] => 2006-08-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 13
[patent_figures_cnt] => 13
[patent_no_of_words] => 13089
[patent_no_of_claims] => 19
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0036/20070036774.pdf
[firstpage_image] =>[orig_patent_app_number] => 11502210
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/502210 | Human liver engrafting cells isolated from adult liver tissue | Aug 8, 2006 | Issued |
Array
(
[id] => 5836774
[patent_doc_number] => 20060248606
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-11-02
[patent_title] => 'Mouse model for hepatitis C'
[patent_app_type] => utility
[patent_app_number] => 11/480012
[patent_app_country] => US
[patent_app_date] => 2006-06-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 5011
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0248/20060248606.pdf
[firstpage_image] =>[orig_patent_app_number] => 11480012
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/480012 | Mouse model for hepatitis C | Jun 28, 2006 | Abandoned |
Array
(
[id] => 5921286
[patent_doc_number] => 20060239975
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-10-26
[patent_title] => 'Methods for treating cancers and restenosis with p21'
[patent_app_type] => utility
[patent_app_number] => 11/475827
[patent_app_country] => US
[patent_app_date] => 2006-06-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 6
[patent_no_of_words] => 5969
[patent_no_of_claims] => 19
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0239/20060239975.pdf
[firstpage_image] =>[orig_patent_app_number] => 11475827
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/475827 | Methods for treating cancers and restenosis with p21 | Jun 26, 2006 | Abandoned |
Array
(
[id] => 12322521
[patent_doc_number] => 09943481
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2018-04-17
[patent_title] => Compositions and methods using same for delivering agents into a target organ protected by a blood barrier
[patent_app_type] => utility
[patent_app_number] => 11/921022
[patent_app_country] => US
[patent_app_date] => 2006-05-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 15
[patent_figures_cnt] => 15
[patent_no_of_words] => 12223
[patent_no_of_claims] => 23
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 101
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 11921022
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/921022 | Compositions and methods using same for delivering agents into a target organ protected by a blood barrier | May 24, 2006 | Issued |
Array
(
[id] => 5236020
[patent_doc_number] => 20070128176
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2007-06-07
[patent_title] => 'Stem cells of the islets of langerhans and their use in treating diabetes mellitus'
[patent_app_type] => utility
[patent_app_number] => 11/438790
[patent_app_country] => US
[patent_app_date] => 2006-05-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 32
[patent_figures_cnt] => 32
[patent_no_of_words] => 25358
[patent_no_of_claims] => 31
[patent_no_of_ind_claims] => 6
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0128/20070128176.pdf
[firstpage_image] =>[orig_patent_app_number] => 11438790
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/438790 | Stem cells of the islets of langerhans and their use in treating diabetes mellitus | May 21, 2006 | Issued |
Array
(
[id] => 5753607
[patent_doc_number] => 20060222756
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-10-05
[patent_title] => 'Medical devices, drug coatings and methods of maintaining the drug coatings thereon'
[patent_app_type] => utility
[patent_app_number] => 11/437572
[patent_app_country] => US
[patent_app_date] => 2006-05-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 20
[patent_figures_cnt] => 20
[patent_no_of_words] => 22061
[patent_no_of_claims] => 34
[patent_no_of_ind_claims] => 6
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0222/20060222756.pdf
[firstpage_image] =>[orig_patent_app_number] => 11437572
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/437572 | Medical devices, drug coatings and methods of maintaining the drug coatings thereon | May 18, 2006 | Abandoned |
Array
(
[id] => 5290485
[patent_doc_number] => 20090023215
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-01-22
[patent_title] => 'Novel reagents for transfection of eukaryotic cells'
[patent_app_type] => utility
[patent_app_number] => 11/434765
[patent_app_country] => US
[patent_app_date] => 2006-05-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 10
[patent_figures_cnt] => 10
[patent_no_of_words] => 27011
[patent_no_of_claims] => 69
[patent_no_of_ind_claims] => 20
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0023/20090023215.pdf
[firstpage_image] =>[orig_patent_app_number] => 11434765
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/434765 | Reagents for transfection of eukaryotic cells | May 16, 2006 | Issued |
Array
(
[id] => 5704785
[patent_doc_number] => 20060193833
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-08-31
[patent_title] => 'Compositions for gene therapy of rheumatoid arthritis including a gene encoding an anti-angiogenic protein or parts thereof'
[patent_app_type] => utility
[patent_app_number] => 11/431526
[patent_app_country] => US
[patent_app_date] => 2006-05-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 6
[patent_no_of_words] => 8175
[patent_no_of_claims] => 8
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0193/20060193833.pdf
[firstpage_image] =>[orig_patent_app_number] => 11431526
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/431526 | Compositions for gene therapy of rheumatoid arthritis including a gene encoding an anti-angiogenic protein or parts thereof | May 10, 2006 | Abandoned |
Array
(
[id] => 5302940
[patent_doc_number] => 20090297592
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-12-03
[patent_title] => 'Lipid Vesicle Composition'
[patent_app_type] => utility
[patent_app_number] => 11/920094
[patent_app_country] => US
[patent_app_date] => 2006-05-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 7
[patent_figures_cnt] => 7
[patent_no_of_words] => 9753
[patent_no_of_claims] => 12
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0297/20090297592.pdf
[firstpage_image] =>[orig_patent_app_number] => 11920094
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/920094 | Lipid Vesicle Composition | May 10, 2006 | Abandoned |
Array
(
[id] => 5682556
[patent_doc_number] => 20060198826
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-09-07
[patent_title] => 'Compositions for gene therapy of rheumatoid arthritis including a gene encoding an anti-angiogenic protein or parts thereof'
[patent_app_type] => utility
[patent_app_number] => 11/431663
[patent_app_country] => US
[patent_app_date] => 2006-05-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 6
[patent_no_of_words] => 8174
[patent_no_of_claims] => 9
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0198/20060198826.pdf
[firstpage_image] =>[orig_patent_app_number] => 11431663
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/431663 | Compositions for gene therapy of rheumatoid arthritis including a gene encoding an anti-angiogenic protein or parts thereof | May 10, 2006 | Abandoned |
Array
(
[id] => 4443253
[patent_doc_number] => 07862652
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2011-01-04
[patent_title] => 'Directional self-assembly of biological electrical interconnects'
[patent_app_type] => utility
[patent_app_number] => 11/418817
[patent_app_country] => US
[patent_app_date] => 2006-05-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 9
[patent_no_of_words] => 17443
[patent_no_of_claims] => 27
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 66
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/862/07862652.pdf
[firstpage_image] =>[orig_patent_app_number] => 11418817
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/418817 | Directional self-assembly of biological electrical interconnects | May 3, 2006 | Issued |
Array
(
[id] => 5290055
[patent_doc_number] => 20090022785
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-01-22
[patent_title] => 'Permeable Capsules'
[patent_app_type] => utility
[patent_app_number] => 11/913491
[patent_app_country] => US
[patent_app_date] => 2006-05-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 7269
[patent_no_of_claims] => 39
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0022/20090022785.pdf
[firstpage_image] =>[orig_patent_app_number] => 11913491
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/913491 | Permeable Capsules | May 2, 2006 | Abandoned |
Array
(
[id] => 5834313
[patent_doc_number] => 20060246143
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-11-02
[patent_title] => 'Targeted therapy via targeted delivery of energy susceptible nanoscale magnetic particles'
[patent_app_type] => utility
[patent_app_number] => 11/410607
[patent_app_country] => US
[patent_app_date] => 2006-04-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 9
[patent_figures_cnt] => 9
[patent_no_of_words] => 10293
[patent_no_of_claims] => 22
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0246/20060246143.pdf
[firstpage_image] =>[orig_patent_app_number] => 11410607
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/410607 | Targeted therapy via targeted delivery of energy susceptible nanoscale magnetic particles | Apr 24, 2006 | Abandoned |
Array
(
[id] => 5642725
[patent_doc_number] => 20060281180
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-12-14
[patent_title] => 'Vectors'
[patent_app_type] => utility
[patent_app_number] => 11/410669
[patent_app_country] => US
[patent_app_date] => 2006-04-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 49
[patent_figures_cnt] => 49
[patent_no_of_words] => 17469
[patent_no_of_claims] => 36
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0281/20060281180.pdf
[firstpage_image] =>[orig_patent_app_number] => 11410669
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/410669 | Vectors | Apr 24, 2006 | Abandoned |
Array
(
[id] => 4866356
[patent_doc_number] => 20080145415
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2008-06-19
[patent_title] => 'Bioresorbable Fillers Constituted by Phospholipid Liposomes and Hyaluronic Acid and/or the Derivatives Thereof'
[patent_app_type] => utility
[patent_app_number] => 11/920009
[patent_app_country] => US
[patent_app_date] => 2006-04-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 5647
[patent_no_of_claims] => 16
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0145/20080145415.pdf
[firstpage_image] =>[orig_patent_app_number] => 11920009
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/920009 | Bioresorbable Fillers Constituted by Phospholipid Liposomes and Hyaluronic Acid and/or the Derivatives Thereof | Apr 20, 2006 | Abandoned |
Array
(
[id] => 4994664
[patent_doc_number] => 20070010009
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2007-01-11
[patent_title] => 'Antibody Composition-Producing Cell'
[patent_app_type] => utility
[patent_app_number] => 11/279748
[patent_app_country] => US
[patent_app_date] => 2006-04-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 52
[patent_figures_cnt] => 52
[patent_no_of_words] => 77436
[patent_no_of_claims] => 1
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0010/20070010009.pdf
[firstpage_image] =>[orig_patent_app_number] => 11279748
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/279748 | Antibody Composition-Producing Cell | Apr 12, 2006 | Abandoned |
Array
(
[id] => 10627629
[patent_doc_number] => 09345768
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2016-05-24
[patent_title] => 'Nanoparticle/active ingredient conjugates'
[patent_app_type] => utility
[patent_app_number] => 11/911196
[patent_app_country] => US
[patent_app_date] => 2006-04-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 8138
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 90
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 11911196
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/911196 | Nanoparticle/active ingredient conjugates | Apr 11, 2006 | Issued |